Sökning: onr:"swepub:oai:DiVA.org:umu-128709" >
Adverse effects of ...
Adverse effects of curative treatment of prostate cancer
-
- Fridriksson, Jon Örn, 1981- (författare)
- Umeå universitet,Urologi och andrologi
-
- Stattin, Pär, Professor (preses)
- Umeå universitet,Urologi och andrologi
-
- Thellenberg-Karlsson, Camilla, M.D., PhD (preses)
- Umeå universitet,Onkologi
-
visa fler...
-
- Lambe, Mats, Professor (preses)
- Department of Medical Epidemiology and Biostatistics (MEB), C8, Karolinska Institutet
-
- Montorsi, Francesco, Professor (opponent)
- Department of Urology, Vita Salute San Raffaele University, Milan, Italy
-
visa färre...
-
(creator_code:org_t)
- ISBN 9789176015599
- Umeå : Umeå universitet, 2016
- Engelska 74 s.
-
Serie: Umeå University medical dissertations, 0346-6612 ; 1846
- Relaterad länk:
-
https://umu.diva-por... (primary) (Raw object)
-
visa fler...
-
https://umu.diva-por...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background Screening for prostate cancer is debated, there is conflicting data on the net benefit of screening. Men who consider screening need to be informed on the pros and cons. Rehospitalization after surgery can be used as an indicator of general quality of care. For radical prostatectomy, little is known on the readmission rate after surgery. Men diagnosed with low- and intermediate-risk prostate cancer have low prostate-cancer specific mortality. However, adverse effects after curative treatment can be severe and decrease quality of life. Curative treatments for prostate cancer differ mainly in the pattern of adverse effects but detailed analysis of long-term adverse effects is lacking.The aim of this thesis was to assess the perioperative quality of radical prostatectomy and the risk of adverse effects after curative treatment for prostate cancer.Material and Methods In this thesis, data from the National Prostate Cancer Register (NPCR) and other nationwide Swedish registers were used. By use of the Swedish personal identity number, NPCR was cross-linked to other registers creating Prostate Cancer data Base Sweden (PCBaSe), a large dataset for research.Results The proportion of men who had received information on the pros and cons of screening for prostate cancer with PSA testing was low (14%) indicating that the majority of men who were screened did not make an informed decision. The risk of rehospitalization within 90 days after radical prostatectomy was approximately 10% and similar after retropubic and robot-assisted radical prostatectomy. Compared to controls, there was an increased risk of adverse effects after both radiotherapy and radical prostatectomy up to twelve years after treatment and the overall risk was quite similar after retropubic and robot-assisted radical prostatectomy.Conclusion Improved information to men on the pros and cons of PSA screening is warranted. The risk of adverse effects was elevated up to 12 years after curative treatment for prostate cancer. The pattern of adverse effects was different after radiotherapy and radical prostatectomy but quite similar after retropubic and robot-assisted radical prostatectomy.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine (hsv//eng)
Nyckelord
- Prostate cancer
- prostate-specific antigen
- decision aids
- radical prostatectomy
- radiotherapy
- patient readmission
- adverse effects
- Urology
- kirurgi, särskilt urologi
Publikations- och innehållstyp
- vet (ämneskategori)
- dok (ämneskategori)
Hitta via bibliotek
Till lärosätets databas